Could routine STI screening during pregnancy prevent preterm births?

NCT ID NCT04446611

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study compares different ways of screening pregnant women for three common sexually transmitted infections (chlamydia, gonorrhea, and trichomonas) to see if treating these infections can reduce the risk of preterm birth and low birth weight. Over 2,200 pregnant women in South Africa are randomly assigned to one of three groups: screening at the first prenatal visit with a follow-up test to confirm cure, screening at the first visit plus a repeat test later in pregnancy, or standard care (treating symptoms only). The study also looks at cost-effectiveness and how the vaginal microbiome may affect treatment success.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
diagnostic screening and treatment for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis
What this could lead to
If effective, this screening strategy could reduce preterm births and low birth weight in regions with high STI rates, improving newborn health and guiding public health policy.
What could go wrong
This is a pragmatic trial comparing screening strategies, not a new drug; results may vary by setting and may not show a clear benefit over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTENATAL CARE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Buffalo City Metro

    East London, Eastern Cape, 5217, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.